A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 213, Issue 3, Pages 411-422
Publisher
Oxford University Press (OUP)
Online
2015-08-11
DOI
10.1093/infdis/jiv406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness
- (2014) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
- Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh
- (2014) Helen Y. Chu et al. JOURNAL OF INFECTIOUS DISEASES
- Gene Sequence Variability of the Three Surface Proteins of Human Respiratory Syncytial Virus (HRSV) in Texas
- (2014) Lorena I. Tapia et al. PLoS One
- An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization
- (2014) Rama Raghunandan et al. VACCINE
- Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries - a systematic review
- (2013) Adeel Ahmed Khan et al. BMC PUBLIC HEALTH
- Neonatal Outcomes After Antenatal Influenza Immunization During the 2009 H1N1 Influenza Pandemic: Impact on Preterm Birth, Birth Weight, and Small for Gestational Age Birth
- (2013) Jennifer L. Richards et al. CLINICAL INFECTIOUS DISEASES
- Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants
- (2013) Benjamin Lindsey et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial
- (2012) M. C. Steinhoff et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy
- (2012) Björn Pasternak et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
- (2012) Gale Smith et al. PLoS One
- Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
- (2012) Gregory M. Glenn et al. VACCINE
- Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis
- (2011) Jessie R. Groothuis et al. ADVANCES IN THERAPY
- IgG Placental Transfer in Healthy and Pathological Pregnancies
- (2011) Patricia Palmeira et al. Clinical & Developmental Immunology
- Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006
- (2011) Lauren J. Stockman et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A Randomized Controlled Trial of Motavizumab Versus Palivizumab for the Prophylaxis of Serious Respiratory Syncytial Virus Disease in Children With Hemodynamically Significant Congenital Heart Disease
- (2011) Timothy F Feltes et al. PEDIATRIC RESEARCH
- Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
- (2011) K. A. Swanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transplacental transport of IgG antibodies to preterm infants: A review of the literature
- (2010) J.P. van den Berg et al. EARLY HUMAN DEVELOPMENT
- Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion
- (2010) K. Huang et al. JOURNAL OF VIROLOGY
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- SAFETY AND ANTIVIRAL ACTIVITY OF MOTAVIZUMAB, A RESPIRATORY SYNCYTIAL VIRUS (RSV)–SPECIFIC HUMANIZED MONOCLONAL ANTIBODY, WHEN ADMINISTERED TO RSV-INFECTED CHILDREN
- (2009) Rosanna Lagos et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial
- (2009) X. Carbonell-Estrany et al. PEDIATRICS
- Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus
- (2008) Joshua J. Shinoff et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of Maternal Influenza Immunization in Mothers and Infants
- (2008) K. Zaman et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started